antibody-drug-conjugates | Media Room

Press Release Dec 11, 2017

ImmunoBiochem Corporation Announces the Completion of a New Round of Financing and Residency at Johnson & Johnson Innovation, JLABS @ Toronto

Press Release Apr 26, 2016

IQ4I Research Published a New Report on "Immune Checkpoints - Hot Targets & Pipeline Analysis"

This pipeline analysis focuses on Immune Checkpoint therapeutics.

Press Release Apr 18, 2016

ImmunoBiochem Corporation Partners With the Centre for the Commercialization of Antibodies and Biologics at the University of Toronto to Advance New Antibody Drug Conjugates

Press Release Feb 17, 2016

Agenda Now Released for the 5th Annual ADC Summit in London

Agenda for the 5th annual ADC Summit presents a lineup of expert speakers from the ADC industry elite including Novartis, Takeda, Roche, Pfizer, MedImmune and Bayer.

Press Release Feb 5, 2016

Takeda Joins 5th ADC Summit to Discuss ADCETRIS Development

SMi reports (05.02.2016, London UK) ADCETRIS Global Medical Lead joins expert speaker panel at the 5th annual ADC Summit in London

Press Release Nov 23, 2010

Oncology at Biogen Idec

Jeremy Barton, VP of Oncology at Biogen Idec will be the keynote presenter on "Targeted Drug Delivery: How Far from the Bulls Eye?" at GTCbio's Cancer Drugs Research & Development Conference in San Diego, CA